Healthcare Professionals

Resolute Onyx™

Drug-Eluting Stent

Expanding PCI Treatment Options for your Patients

Resolute Onyx™ DES is an advanced coronary stent that expands treatment options for complex cases.

Product Details

Resolute Onyx Product Details

4.5- and 5.0-mm sizes — ideally suited for left main and large vessels

  • Maintained structural strength1
  • Minimum foreshortening1

2.0-mm stent sizes — designed for extra-small vessels and tight lesions

  • Lowest crossing profile3
  • 3.25-mm MSID for tapered vessels
Continuous Sinusoid Technology

Core Wire Technology — for optimal treatment of complex cases, including coronary bifurcations

  • Exceptional deliverability3
  • Enhanced radiopacity1 and no compromise to radial or longitudinal strength
  • Greater conformability and flexibility2

Adaptability in coronary bifurcations

  • Open cell design expands for large-vessel sidebranch access1
  • Excellent flexibility and conformability contribute to superior strut appostition2
Sidebranch Cell Size

Core Wire Technology is an evolution of Continuous Sinusoid Technology — and only Resolute Onyx DES has it

Continuous Sinusoid Technology
Flexible stent platform for outstanding flexibility and conformability

Continuous Sinusoid Technology


Core Wire Technology
Thinner struts with enhanced stent visibility for accurate stent placement

Core Wire Technology

Explore Continuous Sinusoid Technology

The most deliverable DES3—  for complex cases

The most deliverable DES —  for complex PCIs

See Resolute Onyx DES in action

See the advantages of 4.5- and 5.0-mm stent sizes in treating extra-large vessels
More information (see more) Less information (see less)

Ready to learn more?

BioLinx™ biocompatible polymer — specifically designed for drug-eluting stents 

  • Same proven durable polymer as Resolute Integrity DES, with excellent safety as demonstrated in the Global RESOLUTE Clinical Program5
  • BIO-RESORT6 and TRANSFORM OCT7 showed no benefit of bioabsorbable polymer DES over durable polymer DES  

See the science behind the BioLinx polymer

A well-balanced delivery system1

  • Greater flexibility
  • A lower crossing profile
  • PowerTrac™ Technology enabling exceptional deliverability
A well balanced delivery system

Product Specifications


Based on bench test data. May not be indicative of clinical performance.


Third-party modeling and analysis. Data may not be indicative of clinical performance.


Based on bench test data vs. Promus Premier™* DES, Synergy™* II DES, Xience Xpedition™* DES, Xience Alpine™* DES, BioMatrix NeoFlex™* DES, Orsiro™* DES, Ultimaster™* DES, and Resolute Integrity™ DES. Bench test data on file at Medtronic. These tests and models may not be indicative of clinical performance.


Compared with 3.0 mm x 18 mm Resolute Integrity™ DES in benchtop testing. Data on file at Medtronic. May not be indicative of clinical performance.


Yeh et al. 5-year safety and efficacy of Resolute zotarolimus-eluting stent, JACC Cardiovascular Interventions. 2017;10:247–254.


Von Birgelen et al. Data presented at TCT 2016. Study not powered for stent thrombosis.


Guagliumi et al. Data presented at PCR 2016. Investigator-initiated study not funded by Medtronic.